WallStSmart
RZLT

Rezolute Inc

NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY

$3.20
+2.56% today

Updated 2026-04-30

Market cap
$293.79M
P/E ratio
P/S ratio
EPS (TTM)
$-0.93
Dividend yield
52W range
$1 – $11
Volume
2.4M

Rezolute Inc (RZLT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20122013201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$4840.00$4.56M$2.40M$5.85M$8.27M$12.57M$0.00$48000.00$18000.00$13000.00$256000.00$382000.00$36000.00$31000.00
Gross profit$-4840.00$-4.56M$-2.40M$-5.85M$-8.27M$-12.57M$0.00$-48000.00$-18000.00$-13000.00$-256000.00$-382000.00$-36000.00$-31000.00
Gross margin
R&D$3494.00$34317.00$4.70M$9.45M$12.09M$17.28M$19.08M$14.45M$14.99M$32.49M$43.81M$55.74M$61.53M
SG&A$42.67M$6.10M$5.13M$6.00M$5.50M$8.23M$9.10M$6.82M$6.07M$7.91M$9.36M$12.18M$14.68M$18.37M
Operating income$-45729.00$-6.11M$-5.18M$-10.70M$-14.95M$-20.32M$-28.73M$-25.94M$-20.52M$-22.89M$-41.84M$-55.99M$-70.42M$-79.89M
Operating margin
EBITDA$-45508.00$-6.16M$-5.49M$-11.22M$-14.18M$-19.16M$-25.18M$-25.44M$-20.32M$-20.51M$-39.24M$-55.96M$-70.39M$-79.86M
EBITDA margin
EBIT$-45729.00$-6.16M$-5.50M$-11.36M$-14.93M$-20.28M$-26.24M$-25.49M$-20.33M$-20.53M$-39.25M$-55.99M$-70.42M$-79.89M
Interest expense$0.00$568859.00$4.23M$6729.00$5039.00$1595.00$689188.00$4.96M$12000.00$375000.00$1.81M$919000.00
Income tax$3558.00$157761.00$336489.00$662723.00$-19822.00$-11367.00$2.93M$-29000.00$-297.00$375000.00$-2.28M$-137895.00$69.71M
Effective tax rate-7.8%-2.4%-3.6%-6.2%0.1%0.1%-10.9%0.1%0.0%-1.8%5.3%0.3%5585.5%0.0%
Net income$-49287.00$-6.73M$-9.73M$-11.36M$-14.94M$-20.28M$-29.86M$-30.42M$-20.33M$-20.90M$-41.06M$-51.79M$-68.46M$-74.41M
Net income growth (YoY)-13549.6%-44.6%-16.8%-31.4%-35.8%-47.3%-1.9%+33.2%-2.8%-96.4%-26.1%-32.2%-8.7%
Profit margin